BioElectronics Corporation, a U.S.-based company headquartered in Frederick, has been making strides in the field of electromagnetic therapeutic applications. Specializing in the development of innovative products aimed at treating soft tissue trauma, the company has positioned itself as a leader in noninvasive medical technology. Their portfolio includes portable and disposable devices designed to accelerate healing, reduce swelling, and alleviate pain associated with cellular trauma.
As of March 26, 2026, BioElectronics Corp’s close price stood at $0.0003, reflecting a significant fluctuation over the past year. The company’s stock has experienced a 52-week high of $0.0014 on February 26, 2026, and a low of $0.0001 on October 8, 2025. These figures highlight the volatility in the company’s market performance, which is not uncommon for firms listed on the OTC Bulletin Board.
With a market capitalization of $7,410,000, BioElectronics Corp continues to attract attention in the biotechnology sector. However, the company’s price-to-earnings ratio remains at -15, indicating that it is not currently generating profits. This negative ratio is often seen in companies that are in the growth phase, investing heavily in research and development to bring new products to market.
BioElectronics Corp’s commitment to innovation is evident in its focus on creating therapeutic solutions that are both effective and user-friendly. The company’s products are designed to be noninvasive, offering a convenient alternative to traditional medical treatments. By leveraging electromagnetic technology, BioElectronics aims to provide relief and recovery solutions that are accessible to a broad range of patients.
For those interested in learning more about BioElectronics Corp’s offerings, further information is available on their website, www.bioelectronicscorp.com . The company continues to trade on the OTC Bulletin Board, providing investors with an opportunity to engage with a firm at the forefront of medical technology innovation.
